Navigation Links
Non-Hormonal Male Contraceptive Based on Sperm Block Underway

A novel, non-hormonal male contraceptive device that targets sperms, called Intra Vas Device (IVD) has been approved by the FDA for a study// involving 90 men. Men and women have long been promised a male version of the female contraceptive pill. However, this first male contraceptive to be marketed market may not be hormonal at all.

The study, to take place in Seattle, Washington and St. Paul, Minnesota, will bring men one-step closer to having their first new contraceptive in more than a century.

‘Preliminary studies in animals and men show that this doesn't have the side effects of hormonal methods,’ said Jim Stice, president of Shepherd Medical Company, a consortium of researchers and entrepreneurs developing the device. ‘The concept is pretty simple: A set of tiny plugs block sperm as they travel through a tube called the vas deferens. Men don't need to worry that they'll have acne or gain weight or have their sex drive go up or down--all things that can happen when you manipulate hormones.’

This will be the second contraceptive study of the IVD in men. In the pilot study, the method was very effective: All 30 men either had no sperm in their semen or had levels too low to cause a pregnancy. Early monkey studies showed reversibility after seven months of use, but reversibility studies in men have thus far only tested same-day insertion and removal.

Elaine Lissner, director of the nonprofit Male Contraception Information Project, is cautiously optimistic. ‘The Holy Grail of contraception is a long-term, reversible method without any hormonal side effects,’ she said. ‘Right now the IVD developers can't guarantee that it's reversible in men like it has been in animals, so they're billing it as a kinder, gentler vasectomy. But if it turns out to be reversible, they're going to have a line out the door.’

The concept of blocking sperm in the vas deferens is not new: each year about 500,000 American men get v
'"/>




Page: 1 2

Related medicine news :

1. Contraceptives via Internet
2. FDA Approves Contraceptive Ring
3. Contraceptives decreases Libido
4. Contraceptives have dual effects
5. Drugs For Anthrax May Interfere With Oral Contraceptives
6. Contraceptive pill to reduce PMS
7. Smoking and Oral Contraceptives:
8. Contraceptive pills may lead to deformities in babies
9. Low-Dose Oral Contraceptives May Increase Risk For Heart Attack Or Stroke
10. Prevent Multiple Sclerosis From Oral Contraceptives
11. Usage Of Oral Contraceptives Need Not Be Feared By SLE Patients
Post Your Comments:
(Date:10/10/2008)...Michigan received $5 million from the National Ins...esource of high-quality experimental data sets of ...mputer-aided drug design to a new level. , The ...puter programs that can predict the effectiveness ...ciate professor in the U-M College of Pharmacy and...
(Date:10/10/2008)... Johns Hopkins University School,of Medicine is la...ptimizing Adjuvant Breast Cancer Strategies: From ...ent key research data on the latest advances in,br...ents in the treatment of breast cancer have,led to...ons that are,increasingly tailored to the specific...
(Date:10/10/2008)... The Mobile Massage Team, (http://www.mobilemassag...massage,services for corporate wellness programs, ... today that it is expanding its service area throu...lphia metropolitan region., "We are quite excited...ed, massage programs and services throughout both...
(Date:10/10/2008)...nationally recognized faculty will,present the ver...east,cancer in the multimedia course "Optimizing A...to Treatment Selection" during National Breast,Can...icing oncologists and other interested,health care...t care,advances. This accredited course offers con...
Breaking Medicine News(10 mins):Health News:U-M to house leading drug database 2Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2Health News:Mobile Massage Team Announces Expansion of On-Site Seated Massage Services Throughout Eastern Pennsylvania and the Greater Philadelphia Region 2Health News:Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer 2
...hildren were still at the threat of suffering from...of the drugs they received during the cancer treat... commonly used class of anticancer drugs known to ... research team investigated two groups of childhoo...
...el Deaconess Medical Center (BIDMC), in collaborat...k Children, Toronto, has confirmed //the previous ...al protein leads to the onset of preeclampsia and ...Flt1, puts preeclampsic patient to a severe condit...
...tralia(COSA), which conducted a review of country ...taff with little or no training, to administer ch...ndicated that the practice posed a risk to these ...nderhill, ‘There's a risk that the patient (might)...
...ontingent left for the earthquake- hit areas of In.... The contingent ,along with a 75-bed field hospit...aft.. Lt Col Naseer Ahmed commands the field ho... general duty doctors, female nurses and 49 parame...
Other Medicine News:Health News:Gene Variations Raise the Risk of Childhood Cancer Survivors 2Health News:Placental Protein Leads To The Onset Of Preeclampsia - Researcher Finds 2Health News:Placental Protein Leads To The Onset Of Preeclampsia - Researcher Finds 3
(Date:10/9/2008)...Newswire-FirstCall/ -- Diamyd Medical reports,that... New England Journal,of Medicine, has published an...the Diamyd(R) diabetes vaccine for type 1 diabetes...080314/297194 ), The article is now available on...d will be in print on October 30. It presents the,...
(Date:10/8/2008)...Pioneers Research That May Offer New Hope to,Heart...- Nationally, over 3,000 people are,waiting for a ... only half,of those will receive a transplant. Now...AHI) is paving the way for how to treat congestive...media News Release, go to:, http://www.prnewswire....
(Date:10/8/2008)...otency of Poly-ICR as Vaccine Adjuvant, SAN DIEGO...aceuticals,Corporation (TSX: NVN) today presented ...roprietary Toll-like Receptor 3 agonist, Poly IC-P...ress 2008 in Lyon, France.,Study results demonstra...ting the Toll-like Receptor 3 (TLR3) pathway. Data...
(Date:10/7/2008)...Newswire/ -- McLaren Health Care and its Great,Lak...d,s leading medical,minds to share the latest work...estinal cancer treatments. The October 11th sympos...McLaren,s Sukamal Saha, M.D., an,award-winning sur...ng for,colorectal cancer has gained worldwide reco...
Breaking Medicine Technology:Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 2Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5News Media Advisory: World's Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments 2Drop of Flu Vaccine Under Tongue Bars Infection 10284 1Drop of Flu Vaccine Under Tongue Bars Infection 10284 2Lessons from evolution applied to national security and other threats 2033 1Lessons from evolution applied to national security and other threats 2033 2Lessons from evolution applied to national security and other threats 2033 3Nycomeds Ciclesonide to be Commercialised in the United States by Sepracor 2783 1Nycomeds Ciclesonide to be Commercialised in the United States by Sepracor 2783 2Nycomeds Ciclesonide to be Commercialised in the United States by Sepracor 2783 3Nycomeds Ciclesonide to be Commercialised in the United States by Sepracor 2783 4Nycomeds Ciclesonide to be Commercialised in the United States by Sepracor 2783 5Nycomeds Ciclesonide to be Commercialised in the United States by Sepracor 2783 6JDRF to establish an autoimmunity center at University of Colorado Denver 10275 1JDRF to establish an autoimmunity center at University of Colorado Denver 10275 2
... Calif., May 17, 2007 /PRNewswire-FirstCall/ -- DU...maceutical has,provided its shareholders with an u...Memryte, an investigational drug for the,treatment...shareholders that they have observed positive outc...ng men. DURECT has not,independently verified the ...
... Md., May 18, 2007 /PRNewswire-FirstCall/ -- Vanda... present four,posters on iloperidone at the 160th ...ing which will be held at the San,Diego Convention...24, 2007. , The following posters will be presente...San Diego Convention Center (Sails,Pavilion, Upper...
Other Medicine Technology:DURECT Provides an Update to the Memryte Program Under Development,by Voyager Pharmaceutical Corp 2Vanda Pharmaceuticals to Present Data on Iloperidone at the 2007,American Psychiatric Association Annual Meeting 2
Phaco chopper 1 mm fully cutting edge.
Round handle dull finish. For right handed surgeon.
Specially designed wider jaws to help split soft nucleus, cross action, round handle, maximum opening 2.8 mm.
Irrigating nucleus chopper, tip angled 30 to side wedge shaped inferior edge with blunt tip and front notch for engaging iris end opening, 19 gauge. For use in the right hand.
Medicine Products: